Serum total bilirubin and long-term prognosis of patients with new-onset non-ST elevation myocardial infarction: a cohort study
暂无分享,去创建一个
[1] Yi Huang,et al. Physiologically increased total bilirubin is associated with reduced risk of first myocardial infarction: A meta-analysis and dose-response analysis. , 2021, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[2] J. Kaski,et al. Total coronary occlusion in non ST elevation myocardial infarction: Time to change our practice? , 2021, International journal of cardiology.
[3] Hongbing Yan,et al. Prognostic Value of Total Bilirubin in Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Coronary Intervention , 2020, Frontiers in Cardiovascular Medicine.
[4] Yanan Xu,et al. Predictive efficacy of neutrophil-to-lymphocyte ratio for long-term prognosis in new onset acute coronary syndrome: a retrospective cohort study , 2020, BMC Cardiovascular Disorders.
[5] S. Doğan,et al. The predictive value of age, creatinine, ejection fraction score for in-hospital mortality in patients with cardiogenic shock. , 2019, Coronary artery disease.
[6] H. Drummond,et al. Targeting Heme Oxygenase-1 in Cardiovascular and Kidney Disease , 2019, Antioxidants.
[7] Fen Liu,et al. Mean platelet volume and coronary plaque vulnerability: an optical coherence tomography study in patients with non-ST-elevation acute coronary syndrome , 2019, BMC Cardiovascular Disorders.
[8] Juan Zhou,et al. Relation of Direct, Indirect, and Total bilirubin to Adverse Long-term Outcomes Among Patients With Acute Coronary Syndrome. , 2019, The American journal of cardiology.
[9] Fen Liu,et al. New Insights into the Association between Fibrinogen and Coronary Atherosclerotic Plaque Vulnerability: An Intravascular Optical Coherence Tomography Study , 2019, Cardiovascular therapeutics.
[10] A. Bulmer,et al. Bilirubin acts as a multipotent guardian of cardiovascular integrity: more than just a radical idea. , 2018, American journal of physiology. Heart and circulatory physiology.
[11] G. Çinier,et al. Clinical characteristics and outcomes of acute coronary syndrome patients with intra-aortic balloon pump inserted in intensive cardiac care unit of a tertiary clinic. , 2018, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[12] Lyanne M. Kieneker,et al. Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach , 2017, Journal of the American Heart Association.
[13] P. Libby,et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.
[14] E. Yıldırım,et al. The Role of Serum Bilirubin Levels in Predicting Troponin Positivity in Non-ST-Segment Elevation Acute Coronary Syndrome , 2017, Angiology.
[15] Yong Peng,et al. The correlation between serum total bilirubin and outcomes in patients with different subtypes of coronary artery disease. , 2017, Clinica chimica acta; international journal of clinical chemistry.
[16] A. Goldfine,et al. Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk. , 2017, The Journal of clinical investigation.
[17] R. Chowdhury,et al. Circulating Total Bilirubin and Risk of Incident Cardiovascular Disease in the General Population , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[18] S. Aydoǧdu,et al. The Prognostic Role of Serum Total Bilirubin in Non-ST Segment Elevation Myocardial Infarction , 2014, Angiology.
[19] O. Uysal,et al. Relation Between Serum Total Bilirubin Levels and Severity of Coronary Artery Disease in Patients With Non-ST-Segment Elevation Myocardial Infarction , 2014, Angiology.
[20] O. Orscelik,et al. Bilirubin Levels and the Burden of Coronary Atherosclerosis in Patients With STEMI , 2013, Angiology.
[21] M. Bozbay,et al. Prognostic value of total bilirubin in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention. , 2013, The American journal of cardiology.
[22] J. Kastelein,et al. Serum bilirubin levels in familial hypercholesterolemia: a new risk marker for cardiovascular disease? , 2011, Journal of Lipid Research.
[23] Kari Kuulasmaa,et al. World Health Organization definition of myocardial infarction: 2008-09 revision. , 2011, International journal of epidemiology.
[24] Y. Kihara,et al. Change in Bilirubin Level Following Acute Myocardial Infarction Is an Index for Heme Oxygenase Activation , 2010, Southern medical journal.
[25] M. Pfeffer,et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program , 2009, European journal of heart failure.
[26] H. Tsutsui. [Candesartan in heart failure: assessment of reduction in mortality and morbidity]. , 2007, Nihon rinsho. Japanese journal of clinical medicine.
[27] R. Wennberg,et al. Interactions of bilirubin with isolated presynaptic nerve terminals: Functional effects on the uptake and release of neurotransmitters , 1993, Cellular and Molecular Neurobiology.
[28] A. Dyer,et al. Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events , 2003 .
[29] Eric J Topol,et al. Prevalence of conventional risk factors in patients with coronary heart disease. , 2003, JAMA.
[30] I. Tikkanen,et al. Expression of heme oxygenase-1 in response to myocardial infarction in rats. , 2002, Journal of molecular and cellular cardiology.
[31] 延吉 正清. Coronary Intervention-欧米との比較- , 1995 .
[32] S. Ebrahim,et al. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. , 1995, Clinical chemistry.